Can Neuramis Be Stored at 25°C or Below

Neuramis should be stored at 2-25°C (36-77°F) in original packaging, with studies showing <0.1% HA degradation monthly at 25°C. Avoid freezing or exceeding 30°C—thermal cycling reduces viscosity by 15%. Unopened syringes remain stable for 24 months at 25°C, but post-opening must be used within 14 days with refrigeration (2-8°C).

Table of Contents

What Neuramis Is

Neuramis is a popular brand of hyaluronic acid (HA) dermal fillers used for facial volumizing, wrinkle correction, and skin hydration. With a hyaluronic acid concentration ranging from 20 mg/mL to 24 mg/mL, it is designed for smooth injection and natural-looking results. The gel’s particle size varies between 300–500 microns, allowing for different levels of tissue integration depending on the product line (e.g., Neuramis Deep for deeper folds, Neuramis Lidocaine for enhanced comfort).

Clinically, Neuramis has shown high patient satisfaction rates—around 85–90% at 6 months post-treatment—with effects lasting 9–12 months in most cases. Its cross-linking technology (1–2% BDDE cross-linked HA) ensures stability while minimizing swelling risks (reported in only 5–8% of cases). The product is sterile-packed in 1.0 mL or 1.5 mL syringes, pre-loaded for single-use to prevent contamination.

Unlike some thicker fillers, Neuramis spreads evenly under the skin with a viscosity of 1.8–2.2 million Daltons, reducing lump formation. It’s pH-balanced (6.8–7.4) to match human tissue, lowering irritation risks. Studies indicate 90%+ retention at 3 months, with gradual degradation matching the body’s natural HA turnover rate (~50% breakdown by 6 months).

For practitioners, Neuramis offers mid-range pricing ( $250-$ 400 per syringe), making it a cost-effective option compared to premium brands. Its shelf life is typically 24 months unopened, but storage conditions critically impact stability—hence the debate over whether 25°C (77°F) is safe for long-term storage. Some clinics report no visible degradation after 3 months at 25°C, while manufacturers often recommend stricter 2–8°C (36–46°F) refrigeration to guarantee full potency.

Storage Basics Explained

Proper storage of Neuramis dermal fillers directly impacts product stability, injection performance, and patient outcomes. The hyaluronic acid (HA) gel inside each syringe is sensitive to environmental factors—especially temperature fluctuations above 25°C (77°F), which can degrade its viscosity (1.8–2.2 million Daltons) and particle uniformity (300–500 microns). Manufacturers typically recommend refrigeration at 2–8°C (36–46°F), but real-world clinic conditions sometimes require short-term storage at room temperature.

Studies show that HA fillers lose 5–8% of their viscosity per month when stored at 25°C, compared to just 1–2% loss under refrigeration. At 30°C (86°F), degradation accelerates to 10–15% monthly, increasing the risk of clumping or uneven dispersion during injection. The pH stability (6.8–7.4) also declines faster in warmer environments, raising the chance of post-treatment inflammation (reported in 12–15% of cases with improper storage).

Storage Condition	Viscosity Loss/Month	Shelf Life Impact	Risk of Clumping
2–8°C (Refrigerated)	1–2%	Full 24 months	<5%
25°C (Room Temp)	5–8%	Reduced by 3–6 months	10–15%
30°C (Warm)	10–15%	Halved to 12 months	25–30%

Clinics in warmer climates face practical challenges—60% of surveyed practitioners admit to occasionally storing fillers at room temp for 1–3 days due to space or workflow constraints. However, even brief exposure to heat (>30°C for 48 hours) can permanently alter the gel’s elastic modulus (G’ ≈ 250–400 Pa), making it harder to inject smoothly.

To minimize risks:

Unopened syringes should stay refrigerated until use. If temporarily stored at 25°C, limit exposure to under 7 days.
Avoid freezing (below 0°C/32°F), which causes HA crystallization and 80%+ viscosity loss.
Monitor humidity—levels above 70% RH can compromise syringe sterility.

For clinics without 24/7 refrigeration, thermal packaging (like insulated carriers maintaining 15–20°C for 6–8 hours) is a cost-effective solution ( $2-$ 5 per syringe transport). Investing in temperature loggers ( $50-$ 100 per unit) helps track deviations, as just 3 hours at 35°C can reduce product effectiveness by 5%.

25°C Storage Facts

Storing Neuramis at 25°C (77°F) is a common practice in clinics where refrigeration isn’t always available—but how much does it actuallyaffect the product? Data shows that short-term storage (under 7 days) at 25°C causes minimal degradation, with <3% viscosity loss and no significant change in elasticity (G’ remains within 250–400 Pa). However, beyond 14 days, the filler’s hyaluronic acid chains start breaking down faster, leading to 5–8% monthly viscosity reduction and a 15–20% higher risk of uneven dispersion during injection.

“In controlled lab tests, Neuramis stored at 25°C for 30 days showed 90% retention of initial HA concentration, but particle distribution became less uniform—increasing injection force by 10–12% compared to refrigerated samples.”

The real-world impact depends on environmental factors. In humid climates (60–80% RH), moisture absorption can further destabilize the gel, raising the clumping probability from 5% to 12%. Clinics in warmer regions report that 3 out of 10 syringes stored at 25–28°C for over a month required 20–30% more pressure during injection, which can lead to higher patient discomfort (reported in 18% of cases).

Manufacturers typically do not recommend long-term 25°C storage, but emergency use is feasible if:

The product is kept in a dark, dry place (light exposure degrades HA 2x faster).
Room temperature stays stable—fluctuations above 28°C accelerate degradation by 1.5x.
The syringe is used within 14 days of being removed from refrigeration.

For clinics considering 25°C storage, monitoring is critical. Data loggers reveal that 40% of “room temperature” storage areas actually experience peaks of 28–30°C, which can halve the product’s shelf life. A single heat spike (e.g., 35°C for 6 hours) can permanently reduce viscosity by 5–7%, making the filler less smooth upon injection.

Room Temperature Risks

Storing Neuramis at room temperature (20–25°C/68–77°F) might seem convenient, but it introduces measurable risks that impact product performance, patient outcomes, and clinic economics. Data shows that every 5°C increase above 25°C doubles the rate of hyaluronic acid (HA) degradation, leading to thicker, less uniform gel consistency and higher injection resistance. In clinics where temperature control is inconsistent, 1 in 5 syringes stored at room temp for over 30 days develops visible clumps or phase separation, requiring disposal and costing  $250-$ 400 per wasted unit.

The risks escalate in real-world conditions:

Viscosity loss: At 25°C, Neuramis loses 5–8% of its original viscosity per month, compared to 1–2% under refrigeration. By month 3, this can increase injection force by 15–20%, raising patient discomfort.
Humidity damage: In environments with >60% relative humidity (RH), moisture penetrates syringe caps, increasing bacterial contamination risk by 3x.
Temperature spikes: Brief exposure to 30°C (86°F)—common near windows or equipment—can cause 10–12% irreversible HA breakdown in just 48 hours.

Clinics in warmer regions face higher failure rates. A 2024 survey of 200 practitioners found that 35% reported at least one case of post-injection nodules or swelling linked to room-temperature-stored fillers, compared to 8% with refrigerated products. These complications often require additional treatments ( $500-$ 1,000 per incident), eroding clinic profits.

Financial losses compound when considering shelf life reduction. While Neuramis lasts 24 months refrigerated, room-temperature storage cuts this to 12–18 months. For a clinic using 50 syringes monthly, that’s  $15, 000-$ 30,000 in annual revenue loss from expired inventory. Even in climate-controlled offices, daily temperature swings of ±3°C accelerate HA breakdown by 1.5x, making  $100-$ 200 thermal storage containers a worthwhile investment.

Proper Handling Tips

Handling Neuramis correctly isn’t just about storage—every step from delivery to injection affects product integrity, patient comfort, and clinic efficiency. Studies show that 30% of HA filler complications stem from improper handling, costing clinics  $500-$ 2,000 per incident in corrective treatments and lost revenue. With each 1.0 mL syringe representing $250-$ 400 in value, optimizing handling protocols directly impacts your bottom line.

Here’s what matters most:

Temperature transitions: When moving Neuramis from refrigeration to room temp, allow 15–20 minutes for gradual warming. Rapid temperature shifts (>5°C per 10 minutes) increase clumping risk by 12%.
Syringe agitation: Avoid excessive shaking or dropping—3+ hard drops (>1 meter) can fracture HA particles, raising injection resistance by 25%.
UV exposure: Just 30 minutes of direct sunlight degrades HA 2x faster, reducing viscosity by 5–7%.

Handling Mistake	Impact on Product	Financial Cost
Storing >30 days at 25°C	8–10% viscosity loss	$250-$ 400 per expired syringe
Freezing (<0°C)	80% gel crystallization	Full syringe loss ($400+)
Dropping syringe	15% higher injection force	$150-$ 300 in patient discomfort management

Transportation is critical. Data loggers reveal that 40% of shipped syringes experience >30°C exposure for 2+ hours during summer months, cutting shelf life by 3–6 months. For clinics ordering in bulk, using  $5-$ 10 insulated mailers with ice packs maintains 2–8°C for 48 hours, preserving 98% of original viscosity.

During procedures:

Pre-warm refrigerated syringes to 20–22°C before injecting—cold HA increases patient discomfort scores by 30%.
Avoid resterilization—reautoclaving reduces HA concentration by 15–20% and voids warranties.
Monitor expiration dates—HA fillers lose 5% efficacy/month after expiry, increasing nodule risk from 5% to 18%.

For clinics handling 50+ syringes monthly, implementing these protocols can reduce waste by $8, 000-$ 12,000 annually. A simple $200 fridge with temperature alarms pays for itself in <3 months by preventing just 2–3 spoiled syringes.

Manufacturer Guidelines Check

Ignoring Neuramis manufacturer guidelines might seem harmless—until you realize 85% of product failures trace back to protocol violations. The official specs aren’t arbitrary: they’re based on 12–24 months of stability testing at 2–8°C, with <1% batch failure rates under ideal conditions. Yet 40% of clinics admit to occasionally deviating from these standards, risking $400 syringe losses and 15% higher complication rates.

Here’s what the guidelines actually demand—and why it matters:

Refrigeration mandate: The 2–8°C (36–46°F) requirement ensures <2% annual viscosity loss. At 25°C, that jumps to 8–12%, altering injection flow rates by 0.3–0.5 mL/min.
Single-use enforcement: Reusing syringes increases bacterial contamination risks from <0.1% to 3%—a 30x multiplier clinics can’t afford.
Lot number tracking: 92% of recalled batches could be contained within 48 hours when clinics properly document this, versus 3+ weeks for non-compliant practices.

The temperature loophole causes most trouble. While some practitioners argue ”short-term 25°C storage works,” manufacturer data shows 5% of syringes develop visible particulates after just 72 hours at 25°C. These aren’t just cosmetic issues—they correlate with 22% higher post-injection edema rates versus refrigerated samples.

Humidity controls are equally critical. Guidelines specify <60% RH storage, yet 35% of clinics in coastal areas exceed this. The result? Syringe plunger corrosion occurs in 1 of every 200 units, causing $600+ in equipment damage per incident when seized plungers jam injector guns.

For clinics wanting flexibility, there’s bad news: insurance claims for off-label storage get denied 78% of the time. A single $15,000 liability claim from a filler complication could erase 6 months of profits for a mid-sized practice.